ATE180671T1 - Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe - Google Patents
Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabeInfo
- Publication number
- ATE180671T1 ATE180671T1 AT92202940T AT92202940T ATE180671T1 AT E180671 T1 ATE180671 T1 AT E180671T1 AT 92202940 T AT92202940 T AT 92202940T AT 92202940 T AT92202940 T AT 92202940T AT E180671 T1 ATE180671 T1 AT E180671T1
- Authority
- AT
- Austria
- Prior art keywords
- injectable formulations
- oil
- cascin
- hydrated
- extended
- Prior art date
Links
- 239000007972 injectable composition Substances 0.000 title abstract 3
- 238000013265 extended release Methods 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 3
- 239000005660 Abamectin Substances 0.000 abstract 2
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 2
- 239000004359 castor oil Substances 0.000 abstract 2
- 235000019438 castor oil Nutrition 0.000 abstract 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- -1 avermectin compound Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002687 nonaqueous vehicle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76879791A | 1991-09-30 | 1991-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE180671T1 true ATE180671T1 (de) | 1999-06-15 |
Family
ID=25083508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92202940T ATE180671T1 (de) | 1991-09-30 | 1992-09-24 | Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0535734B1 (de) |
| JP (1) | JPH0672108B2 (de) |
| AT (1) | ATE180671T1 (de) |
| AU (1) | AU2603792A (de) |
| CA (1) | CA2079255A1 (de) |
| DE (1) | DE69229318T2 (de) |
| DK (1) | DK0535734T3 (de) |
| ES (1) | ES2131515T3 (de) |
| GR (1) | GR3030403T3 (de) |
| ZA (1) | ZA927457B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9300883D0 (en) * | 1993-01-18 | 1993-03-10 | Pfizer Ltd | Antiparasitic agents |
| US5981500A (en) * | 1994-01-12 | 1999-11-09 | Pfizer Inc. | Antiparasitic agents related to the milbemycins and avermectins |
| DE19613972A1 (de) * | 1996-04-09 | 1997-10-16 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl |
| DE19638045A1 (de) * | 1996-09-18 | 1998-03-19 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen |
| DE69818093T2 (de) * | 1997-12-03 | 2004-06-09 | Merck & Co., Inc. | Langwirkende, injizierbare, formulierungen enthaltend rizinusöl |
| US6174540B1 (en) | 1998-09-14 | 2001-01-16 | Merck & Co., Inc. | Long acting injectable formulations containing hydrogenated caster oil |
| GB9827727D0 (en) | 1998-12-16 | 1999-02-10 | Pfizer Ltd | Antiparasitic formulations |
| KR100355116B1 (ko) * | 2000-02-17 | 2002-10-11 | 주식회사 엘지씨아이 | 애버멕틴 유도체를 포함하는 기생충 박멸용 사료 프레믹스조성물 및 그 제조방법 |
| KR20020067781A (ko) * | 2001-02-19 | 2002-08-24 | 주식회사 엘지씨아이 | 구충용 이버멕틴 주사제 조성물 및 그 제조방법 |
| US6653288B1 (en) | 2002-09-30 | 2003-11-25 | Virbac S.A. | Injectable anthelmintic compositions and methods for using same |
| WO2004045581A1 (fr) * | 2002-11-18 | 2004-06-03 | Yuwan Wang | Injection d'une suspension d'un antiparasite veterinaire |
| WO2004103343A1 (fr) * | 2003-05-25 | 2004-12-02 | Yuwan Wang | Formulation a liberation prolongee a base de dimethicone |
| WO2005084688A1 (en) * | 2004-03-04 | 2005-09-15 | Yuwan Wang | An injection power containing vermifuge |
| US8362086B2 (en) | 2005-08-19 | 2013-01-29 | Merial Limited | Long acting injectable formulations |
| NZ552040A (en) * | 2006-12-13 | 2009-04-30 | Bomac Research Ltd | Veterinary formulation comprising an anthelmintic compound and glyceryl acetate |
| EP2825154A4 (de) * | 2012-03-13 | 2015-11-11 | Bayer New Zealand Ltd | Lang wirkende zusammensetzungen |
| CN103705445A (zh) * | 2014-01-06 | 2014-04-09 | 王玉万 | 含乙酰甲喹/氢化蓖麻油的原位胶凝注射剂 |
| CN103721266A (zh) * | 2014-01-06 | 2014-04-16 | 王玉万 | 含阿维菌素类药物/氢化蓖麻油的原位胶凝注射剂 |
| CN113563395B (zh) * | 2021-08-09 | 2023-06-02 | 河北威远生物化工有限公司 | 一种阿维菌素b2衍生物及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL78621A (en) * | 1985-04-30 | 1991-06-30 | American Cyanamid Co | Mylbemycin analogs,their preparation and pesticidal compositions containing them |
| NZ234802A (en) * | 1989-08-14 | 1992-11-25 | Merck & Co Inc | Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals |
-
1992
- 1992-09-24 DE DE69229318T patent/DE69229318T2/de not_active Expired - Lifetime
- 1992-09-24 DK DK92202940T patent/DK0535734T3/da active
- 1992-09-24 AT AT92202940T patent/ATE180671T1/de active
- 1992-09-24 EP EP92202940A patent/EP0535734B1/de not_active Expired - Lifetime
- 1992-09-24 ES ES92202940T patent/ES2131515T3/es not_active Expired - Lifetime
- 1992-09-28 JP JP4258050A patent/JPH0672108B2/ja not_active Expired - Lifetime
- 1992-09-28 CA CA002079255A patent/CA2079255A1/en not_active Abandoned
- 1992-09-29 AU AU26037/92A patent/AU2603792A/en not_active Abandoned
- 1992-09-29 ZA ZA927457A patent/ZA927457B/en unknown
-
1999
- 1999-06-03 GR GR990401373T patent/GR3030403T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05246893A (ja) | 1993-09-24 |
| DE69229318T2 (de) | 1999-11-18 |
| GR3030403T3 (en) | 1999-09-30 |
| EP0535734B1 (de) | 1999-06-02 |
| DK0535734T3 (da) | 1999-08-09 |
| ES2131515T3 (es) | 1999-08-01 |
| DE69229318D1 (de) | 1999-07-08 |
| CA2079255A1 (en) | 1993-03-31 |
| AU2603792A (en) | 1993-04-01 |
| ZA927457B (en) | 1993-04-07 |
| JPH0672108B2 (ja) | 1994-09-14 |
| EP0535734A1 (de) | 1993-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE180671T1 (de) | Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe | |
| HUT71889A (en) | Pharmaceutical compositions containing terfenadine metabolites and their optically pure isomers for treating allergic disorders | |
| AU681452B2 (en) | Pernasal composition and pernasal preparation containing thesame | |
| ES2242218T3 (es) | Composiciones farmaceuticas que contienen aceite de semilla del arbol candil. | |
| EP0443007A4 (en) | An external analgesic lotion and method of making | |
| TW234691B (de) | ||
| FI955403A0 (fi) | Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä | |
| CA2284774A1 (en) | Theobromine antitussive compositions | |
| DK0550719T3 (da) | Neutralt implanteringssystem | |
| EP0535237A4 (en) | Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same | |
| ES2134237T3 (es) | Composiciones farmaceuticas que contienen acido ursodesoxicolico. | |
| ATE337333T1 (de) | Ophthalmische arzneimittelzusammenstellung | |
| ITRM910730A1 (it) | Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali. | |
| JPS5714517A (en) | Whitening cosmetic | |
| AU4519189A (en) | Medicaments for the treatment of toxoplasmosis | |
| AU4519289A (en) | Medicament for the treatment of cryptosporidiosis | |
| IT1247936B (it) | Composizioni farmaceutiche per il trattamento di dermatosi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |